Indolent T-lymphoblastic proliferation with fibrolamellar hepatocellular carcinoma developed after colorectal adenocarcinoma: a case report

Objective: Indolent T-lymphoblastic proliferation (iT-LBP) is a non-neoplastic disease with an indolent clinical course, manifesting as hyperplasia of immature extrathymic T-lymphoblastic cells. Isolated iT-LBP has been observed, but the majority of iT-LBP cases has been seen in conjunction with oth...

Full description

Bibliographic Details
Main Authors: Wen Han, Bei Wang, Xiang Yong, Yi Zhang, Mingyu Shao, Chun Wang
Format: Article
Language:English
Published: Frontiers Media S.A. 2023-05-01
Series:Pathology and Oncology Research
Subjects:
Online Access:https://www.por-journal.com/articles/10.3389/pore.2023.1611151/full
_version_ 1797221089298874368
author Wen Han
Bei Wang
Xiang Yong
Yi Zhang
Mingyu Shao
Chun Wang
author_facet Wen Han
Bei Wang
Xiang Yong
Yi Zhang
Mingyu Shao
Chun Wang
author_sort Wen Han
collection DOAJ
description Objective: Indolent T-lymphoblastic proliferation (iT-LBP) is a non-neoplastic disease with an indolent clinical course, manifesting as hyperplasia of immature extrathymic T-lymphoblastic cells. Isolated iT-LBP has been observed, but the majority of iT-LBP cases has been seen in conjunction with other diseases. iT-LBP is easily misdiagnosed as T-lymphoblastic lymphoma/leukemia, and understanding the disease of indolent T-lymphoblastic proliferation may prevent misdiagnosis and missed diagnosis in pathological diagnosis.Case presentation: We report a case morphology, immunophenotypic, and molecular features of iT-LBP combined with fibrolamellar hepatocellular carcinoma developed after colorectal adenocarcinoma and review relevant literature.Conclusion: iT-LBP combined with fibrolamellar hepatocellular carcinoma developed after colorectal adenocarcinoma is relatively rare and should always be considered as a differential diagnosis of T-lymphoblastic lymphoma and scirrhous hepatocellular carcinoma as the two disorders show highly similar clinical features.
first_indexed 2024-04-24T12:59:53Z
format Article
id doaj.art-99c9a3166e7f40f192801a7997612f3c
institution Directory Open Access Journal
issn 1532-2807
language English
last_indexed 2024-04-24T12:59:53Z
publishDate 2023-05-01
publisher Frontiers Media S.A.
record_format Article
series Pathology and Oncology Research
spelling doaj.art-99c9a3166e7f40f192801a7997612f3c2024-04-05T16:15:46ZengFrontiers Media S.A.Pathology and Oncology Research1532-28072023-05-012910.3389/pore.2023.16111511611151Indolent T-lymphoblastic proliferation with fibrolamellar hepatocellular carcinoma developed after colorectal adenocarcinoma: a case reportWen Han0Bei Wang1Xiang Yong2Yi Zhang3Mingyu Shao4Chun Wang5Department of Pathology, People’s Hospital of Xinjiang Uygur Autonomous Region, Urumqi, ChinaGraduate Education Department, People’s Hospital of Xinjiang Uygur Autonomous Region, Urumqi, ChinaDepartment of Pathology, Anhui Wanbei Coal-Electricity Group General Hospital, Suzhou, ChinaDepartment of Pathology, People’s Hospital of Xinjiang Uygur Autonomous Region, Urumqi, ChinaDepartment of Pathology, People’s Hospital of Xinjiang Uygur Autonomous Region, Urumqi, ChinaDepartment of Pathology, People’s Hospital of Xinjiang Uygur Autonomous Region, Urumqi, ChinaObjective: Indolent T-lymphoblastic proliferation (iT-LBP) is a non-neoplastic disease with an indolent clinical course, manifesting as hyperplasia of immature extrathymic T-lymphoblastic cells. Isolated iT-LBP has been observed, but the majority of iT-LBP cases has been seen in conjunction with other diseases. iT-LBP is easily misdiagnosed as T-lymphoblastic lymphoma/leukemia, and understanding the disease of indolent T-lymphoblastic proliferation may prevent misdiagnosis and missed diagnosis in pathological diagnosis.Case presentation: We report a case morphology, immunophenotypic, and molecular features of iT-LBP combined with fibrolamellar hepatocellular carcinoma developed after colorectal adenocarcinoma and review relevant literature.Conclusion: iT-LBP combined with fibrolamellar hepatocellular carcinoma developed after colorectal adenocarcinoma is relatively rare and should always be considered as a differential diagnosis of T-lymphoblastic lymphoma and scirrhous hepatocellular carcinoma as the two disorders show highly similar clinical features.https://www.por-journal.com/articles/10.3389/pore.2023.1611151/fulldifferential diagnosisindolent T-lymphoblastic proliferationiT-LBPfibrolamellar hepatocellular carcinomaT-lymphoblastic lymphoma
spellingShingle Wen Han
Bei Wang
Xiang Yong
Yi Zhang
Mingyu Shao
Chun Wang
Indolent T-lymphoblastic proliferation with fibrolamellar hepatocellular carcinoma developed after colorectal adenocarcinoma: a case report
Pathology and Oncology Research
differential diagnosis
indolent T-lymphoblastic proliferation
iT-LBP
fibrolamellar hepatocellular carcinoma
T-lymphoblastic lymphoma
title Indolent T-lymphoblastic proliferation with fibrolamellar hepatocellular carcinoma developed after colorectal adenocarcinoma: a case report
title_full Indolent T-lymphoblastic proliferation with fibrolamellar hepatocellular carcinoma developed after colorectal adenocarcinoma: a case report
title_fullStr Indolent T-lymphoblastic proliferation with fibrolamellar hepatocellular carcinoma developed after colorectal adenocarcinoma: a case report
title_full_unstemmed Indolent T-lymphoblastic proliferation with fibrolamellar hepatocellular carcinoma developed after colorectal adenocarcinoma: a case report
title_short Indolent T-lymphoblastic proliferation with fibrolamellar hepatocellular carcinoma developed after colorectal adenocarcinoma: a case report
title_sort indolent t lymphoblastic proliferation with fibrolamellar hepatocellular carcinoma developed after colorectal adenocarcinoma a case report
topic differential diagnosis
indolent T-lymphoblastic proliferation
iT-LBP
fibrolamellar hepatocellular carcinoma
T-lymphoblastic lymphoma
url https://www.por-journal.com/articles/10.3389/pore.2023.1611151/full
work_keys_str_mv AT wenhan indolenttlymphoblasticproliferationwithfibrolamellarhepatocellularcarcinomadevelopedaftercolorectaladenocarcinomaacasereport
AT beiwang indolenttlymphoblasticproliferationwithfibrolamellarhepatocellularcarcinomadevelopedaftercolorectaladenocarcinomaacasereport
AT xiangyong indolenttlymphoblasticproliferationwithfibrolamellarhepatocellularcarcinomadevelopedaftercolorectaladenocarcinomaacasereport
AT yizhang indolenttlymphoblasticproliferationwithfibrolamellarhepatocellularcarcinomadevelopedaftercolorectaladenocarcinomaacasereport
AT mingyushao indolenttlymphoblasticproliferationwithfibrolamellarhepatocellularcarcinomadevelopedaftercolorectaladenocarcinomaacasereport
AT chunwang indolenttlymphoblasticproliferationwithfibrolamellarhepatocellularcarcinomadevelopedaftercolorectaladenocarcinomaacasereport